Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C

Pokorska-Spiewak M, Kowalik-Mikolajewska B, Aniszewska M, Pluta M, Marczynska M. Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C. Clin Exp Hepatol. 2017;3:198-202.

Publication Type:

Journal Article

Authors:

Pokorska-Spiewak, M; Kowalik-Mikolajewska, B; Aniszewska, M; Pluta, M; Marczynska, M

Source:

Clin Exp Hepatol, Volume 3, p.198-202 (2017)

Cited On:

HCV in Children

Export Citation:

RIS Format

Top